Stay updated on Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial
Sign up to get notified when there's something new on the Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial page.

Latest updates to the Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRelated topics were added (Multiple myeloma; MedlinePlus Genetics) and the revision tag was updated from v3.3.1 to v3.3.2. These are minor metadata changes and do not alter the trial details or outcomes.SummaryDifference0.1%

- Check25 days agoChange DetectedPublications section text updated to reflect PubMed auto-filled entries, and the revision version was updated to v3.3.1; the older PubMed-related description (v3.2.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedRemoved the notice about a lapse in government funding and the NIH Clinical Center’s operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check46 days agoChange DetectedThe two screenshots show no meaningful differences in core content or layout; the study details, eligibility criteria, and trial arms remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check61 days agoChange DetectedAdded new MedlinePlus Genetics topic: Multiple myeloma, expanding the page's coverage in health/genetics.SummaryDifference0.1%

- Check68 days agoChange DetectedRemoved a MedlinePlus Genetics topic on multiple myeloma, reducing access to genetic information about this condition. No new content was added.SummaryDifference0.1%

Stay in the know with updates to Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial page.